Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016 (2016), Article ID 8285041, 8 pages
http://dx.doi.org/10.1155/2016/8285041
Research Article

Goal Setting for Cognitive Rehabilitation in Mild to Moderate Parkinson’s Disease Dementia and Dementia with Lewy Bodies

1School of Psychology, Bangor University, Bangor LL57 2AS, UK
2Department of Care for the Elderly, Betsi Cadwaladr University Health Board, Llandudno LL30 1LB, UK
3The College of Health & Behavioural Sciences, Bangor University, Bangor LL57 2UW, UK
4Division of Mental Health and Learning Disabilities, Betsi Cadwaladr University Health Board, Ysbyty Gwynedd, Bangor LL57 2PW, UK
5Centre for Research in Ageing and Cognitive Health (REACH), School of Psychology, University of Exeter, Exeter EX4 4QG, UK
6PenCLAHRC, Institute of Health Research, University of Exeter Medical School, Exeter EX1 2LU, UK
7Centre for Health Economics and Medicines Evaluation (CHEME), Bangor University, Normal Site, Bangor LL57 2PZ, UK
8The North Wales Organisation for Randomised Trials in Health (NWORTH), Bangor University, Gwynedd, Bangor LL57 2PZ, UK
9Cefni Hospital, Llangefni, Anglesey LL77 7PP, UK

Received 31 March 2016; Accepted 1 June 2016

Academic Editor: Tien K. Khoo

Copyright © 2016 Tamlyn J. Watermeyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Hely, W. G. J. Reid, M. A. Adena, G. M. Halliday, and J. G. L. Morris, “The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years,” Movement Disorders, vol. 23, no. 6, pp. 837–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Kehagia, R. A. Barker, and T. W. Robbins, “Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease,” The Lancet Neurology, vol. 9, no. 12, pp. 1200–1213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Tsuboi and D. W. Dickson, “Dementia with Lewy bodies and Parkinson’s disease with dementia: are they different?” Parkinsonism and Related Disorders, vol. 11, supplement 1, pp. S47–S51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Aarsland, “Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies,” Parkinsonism and Related Disorders, vol. 22, supplement, pp. S144–S148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. C. C. Janvin, J. P. Larsen, D. P. Salmon, D. Galasko, K. Hugdahl, and D. Aarsland, “Cognitive profiles of individual patients with Parkinson’s disease and dementia: comparison with dementia with Lewy bodies and Alzheimer’s disease,” Movement Disorders, vol. 21, no. 3, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Noe, K. Marder, K. L. Bell, D. M. Jacobs, J. J. Manly, and Y. Stern, “Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia,” Movement Disorders, vol. 19, no. 1, pp. 60–67, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Meireles and J. Massano, “Cognitive impairment and dementia in Parkinson’s disease: clinical features, diagnosis, and management,” Frontiers in Neurology, vol. 3, article 88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Seltzer, J. J. Vasterling, C. W. Mathias, and A. Brennan, “Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study,” Neuropsychiatry, Neuropsychology and Behavioral Neurology, vol. 14, no. 2, pp. 122–129, 2001. View at Google Scholar · View at Scopus
  9. E. Leritz, C. Loftis, G. Crucian, W. Friedman, and D. Bowers, “Self-awareness of deficits in Parkinson disease,” The Clinical Neuropsychologist, vol. 18, no. 3, pp. 352–361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. E. J. Sitek, W. Sołtan, D. Wieczorek, P. Robowski, and J. Sławek, “Self-awareness of memory function in Parkinson’s disease in relation to mood and symptom severity,” Aging and Mental Health, vol. 15, no. 2, pp. 150–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kudlicka, L. Clare, and J. V. Hindle, “Awareness of executive deficits in people with Parkinson’s disease,” Journal of the International Neuropsychological Society, vol. 19, no. 5, pp. 559–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Goldsworthy and S. Knowles, “Caregiving for Parkinson’s disease patients: an exploration of a stress-appraisal model for quality of life and burden,” Journals of Gerontology—Series B Psychological Sciences and Social Sciences, vol. 63, no. 6, pp. P372–P376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Aarsland, J. P. Larsen, K. Karlsen, N. G. Lim, and E. Tandberg, “Mental symptoms in Parkinson's disease are important contributors to caregiver distress,” International Journal of Geriatric Psychiatry, vol. 14, no. 10, pp. 866–874, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Stella, C. E. M. Banzato, E. M. A. B. Quagliato, M. A. Viana, and G. Christofoletti, “Psychopathological features in patients with Parkinson’s disease and related caregivers’ burden,” International Journal of Geriatric Psychiatry, vol. 24, no. 10, pp. 1158–1165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Leroi, V. Harbishettar, M. Andrews, K. McDonald, E. J. Byrne, and A. Burns, “Carer burden in apathy and impulse control disorders in Parkinson’s disease,” International Journal of Geriatric Psychiatry, vol. 27, no. 2, pp. 160–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Kudlicka, L. Clare, and J. V. Hindle, “Quality of life, health status and caregiver burden in Parkinson’s disease: relationship to executive functioning,” International Journal of Geriatric Psychiatry, vol. 29, no. 1, pp. 68–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Boström, L. Jönsson, L. Minthon, and E. Londos, “Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 21, no. 2, pp. 150–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. N. Leggett, S. Zarit, A. Taylor, and J. E. Galvin, “Stress and burden among caregivers of patients with lewy body dementia,” The Gerontologist, vol. 51, no. 1, pp. 76–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Pagano, G. Rengo, G. Pasqualetti et al., “Cholinesterase inhibitors for Parkinson’s disease: a systematic review and meta-analysis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 7, pp. 767–773, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Emre, M. Tsolaki, U. Bonuccelli et al., “Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial,” The Lancet Neurology, vol. 9, no. 10, pp. 969–977, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. V. Hindle, A. Petrelli, L. Clare, and E. Kalbe, “Nonpharmacological enhancement of cognitive function in Parkinson’s disease: a systematic review,” Movement Disorders, vol. 28, no. 8, pp. 1034–1049, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. G. Goldman and D. Weintraub, “Advances in the treatment of cognitive impairment in Parkinson’s disease,” Movement Disorders, vol. 30, no. 11, pp. 1471–1489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. V. Hindle, T. J. Watermeyer, J. Roberts et al., “Cognitive rehabiliation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial,” Trials, vol. 17, no. 1, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  24. L. Clare, D. E. J. Linden, R. T. Woods et al., “Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy,” American Journal of Geriatric Psychiatry, vol. 18, no. 10, pp. 928–939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Clare, A. Bayer, A. Burns et al., “Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT),” Trials, vol. 14, article 152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hsieh, S. Schubert, C. Hoon, E. Mioshi, and J. R. Hodges, “Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and Alzheimer’s disease,” Dementia and Geriatric Cognitive Disorders, vol. 36, no. 3-4, pp. 242–250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Clare, J. V. Hindle, I. R. Jones et al., “The AgeWell study of behavior change to promote health and wellbeing in later life: study protocol for a randomized controlled trial,” Trials, vol. 13, article 115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. World Medical Association, “World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects,” The Journal of the American Medical Association, vol. 310, no. 20, pp. 2191–2194, 2013. View at Publisher · View at Google Scholar
  29. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression, and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Fahn and R. Elton, “Members of the United Parkinson’s Disease Rating Scale (UPDRS) development committee,” in Recent Developments in Parkinson’s Disease, S. Fahn, C. D. Marsden, D. B. Calne, and M. Goldstein, Eds., Macmillan Health Care Information, Florham Park, NJ, USA, 1987. View at Google Scholar
  31. A. S. Zigmond and R. P. Snaith, “The Hospital Anxiety and Depression Scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Crawford, J. D. Henry, C. Crombie, and E. P. Taylor, “Normative data for the HADS from a large non-clinical sample,” British Journal of Clinical Psychology, vol. 40, no. 4, pp. 429–434, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. IBM Corp, IBM SPSS Statistics for Windows, IBM Corp, Armonk, NY, USA, 2013.
  34. T. J. Bovend’Eerdt, R. E. Botell, and D. T. Wade, “Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide,” Clinical Rehabilitation, vol. 23, no. 4, pp. 352–361, 2009. View at Google Scholar
  35. M. Vaismoradi, J. Jones, H. Turunen, and S. Snelgrove, “Theme development in qualitative content analysis and thematic analysis,” Journal of Nursing Education and Practice, vol. 6, no. 5, pp. 100–110, 2015. View at Publisher · View at Google Scholar
  36. L. Clare, A. Bayer, A. Burns et al., “Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT),” Trials, vol. 14, no. 1, article 152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Krippendorff and R. Craggs, Multiple Valued Nominal Alpha (Version 1.0), 2015, http://www.asc.upenn.edu/mvnAlpha, https://github.com/rcraggs/mvna/releases.
  38. A. F. Hayes and K. Krippendorff, “Answering the call for a standard reliability measure for coding data,” Communication Methods and Measures, vol. 1, no. 1, pp. 77–89, 2007. View at Publisher · View at Google Scholar
  39. A. Elbaz, J. H. Bower, D. M. Maraganore et al., “Risk tables for parkinsonism and Parkinson’s disease,” Journal of Clinical Epidemiology, vol. 55, no. 1, pp. 25–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. T. T. Vlagsma, J. Koerts, L. Fasotti et al., “Parkinson's patients executive profile and goals they set for improvement: why is cognitive rehabilitation not common practice?” Neuropsychological Rehabilitation, vol. 26, no. 2, pp. 216–235, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. D. J. Daley, P. K. Myint, R. J. Gray, and K. H. O. Deane, “Systematic review on factors associated with medication non-adherence in Parkinson’s disease,” Parkinsonism and Related Disorders, vol. 18, no. 10, pp. 1053–1061, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Quinn, L. Clare, and B. Woods, “The impact of the quality of relationship on the experiences and wellbeing of caregivers of people with dementia: a systematic review,” Aging and Mental Health, vol. 13, no. 2, pp. 143–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Martyr, L. Clare, S. M. Nelis et al., “Verbal fluency and awareness of functional deficits in early-stage dementia,” The Clinical Neuropsychologist, vol. 26, no. 3, pp. 501–519, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Martyr, S. M. Nelis, and L. Clare, “Predictors of perceived functional ability in early-stage dementia: self-ratings, informant ratings and discrepancy scores,” International Journal of Geriatric Psychiatry, vol. 29, no. 8, pp. 852–862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Razani, B. Kakos, C. Orieta-Barbalace et al., “Predicting caregiver burden from daily functional abilities of patients with mild dementia,” Journal of the American Geriatrics Society, vol. 55, no. 9, pp. 1415–1420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Slachevsky, M. Budinich, C. Miranda-Castillo et al., “The CUIDEME study: determinants of burden in Chilean primary caregivers of patients with dementia,” Journal of Alzheimer’s Disease, vol. 35, no. 2, pp. 297–306, 2013. View at Publisher · View at Google Scholar · View at Scopus